Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 0

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Schedule 14A

Proxy Statement Pursuant
to Section 14(a) of
the Securities Exchange Act of 1934</div>

| Filed by the Registrant                    | ☒ |
| Filed by a party other than the Registrant | ☐ |

Check the appropriate box:

| ☒ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☐ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material under § 240.14a-12                                          |

| 60 DEGREES PHARMACEUTICALS, INC.                                         |
| (Name of Registrant as Specified In Its Charter)                         |
| N/A                                                                      |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |

Payment of Filing Fee (Check all boxes that apply):

| ☒ | No fee required |

| ☐ | Fee paid previously with preliminary 
 materials.                           |

| ☐ | Fee computed on table in exhibit                                    
 required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11 |

<div align='center'>60 DEGREES PHARMACEUTICALS, INC.

1025 Connecticut Avenue NW Suite 1000
Washington, D.C. 20036

https://60degreespharma.com</div>

August [_], 2025

Dear Fellow Stockholders:

On behalf of your Board of Directors, we cordially
invite you to attend the 2025 Annual Meeting of Stockholders of 60 Degrees Pharmaceuticals, Inc. (the “Annual Meeting”). The
Annual Meeting will be held on October 8, 2025, at 12:00 p.m. Eastern Time, in a virtual meeting format only and conducted via live audio
webcast over the telephone to enable our stockholders to participate from locations around the world. Stockholders will NOT be
able to attend the Annual Meeting in person. The Annual Meeting will be accessible only over the telephone. Please see “Attending
the Virtual Annual Meeting” in the proxy statement (“Proxy Statement”) accompanying this letter for information on how
to obtain the proxy materials, attend, ask questions at the